symbicort turbuhaler 4,5+160 mikrog/dosis inhalationspulver
europharma.dk aps - budesonid, formoterolfumarat dihydrat - inhalationspulver - 4,5+160 mikrog/dosis
symbicort forte turbohaler 9+320 mikrog./dosis inhalationspulver
2care4 aps - budesonid, formoterolfumarat dihydrat - inhalationspulver - 9+320 mikrog./dosis
symbicort forte turbohaler 9+320 mikrog/dosis inhalationspulver
paranova danmark a/s - budesonid, formoterolfumarat dihydrat - inhalationspulver - 9+320 mikrog/dosis
symbicort forte turbuhaler 9+320 mikrog./dosis inhalationspulver
europharma.dk aps - budesonid, formoterolfumarat dihydrat - inhalationspulver - 9+320 mikrog./dosis
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
intestifalk 3 mg enterokapsler, hårde
2care4 aps - budesonid - enterokapsler, hårde - 3 mg
kinpeygo
stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrémidler, tarm antiinflammatorisk / antiinfective agenter - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.
miflonide breezhaler 400 mikrogram inhalationspulver, hård kapsel
orifarm a/s - budesonid - inhalationspulver, hård kapsel - 400 mikrogram
miflonide breezhaler 400 mikrogram inhalationspulver, hård kapsel
2care4 aps - budesonid - inhalationspulver, hård kapsel - 400 mikrogram